Morbidity and Mortality Associated With Nosocomial Transmission of Oseltamivir- Resistant Influenza A(H1N1) Virus

Abstract

Context The sudden emergence and rapid spread of oseltamivir-resistant influenza A(H1N1) viruses with neuraminidase (NA) gene H274Y amino acid substitution is the hallmark of global seasonal influenza since January 2008. Viruses carrying this mutation are widely presumed to exhibit attenuated pathogenicity, compromised transmission, and reduced lethality. Objective To investigate nosocomial viral transmission in a cluster of patients with influenza A(H1N1) virus infection. Design, Setting, and Patients Descriptive outbreak investigation of 2 hematopoietic stem cell transplant recipients and an elderly patient who developed hospitalacquired influenza A virus infection following exposure to an index patient with community-acquired H274Y-mutated influenza A(H1N1) virus infection in a medical ward at a Dutch university hospital in February 2008. The investigation included a review of the medical records, influenza virus polymerase chain reaction and culture, phenotypic oseltamivir and zanamivir susceptibility determination, and hemagglutinin chain 1 (HA 1) gene and NA gene sequence analysis. Main Outcome Measure Phylogenetic relationship of patient cluster influenza A(H1N1) viruses and other 2007-2008 seasonal influenza A(H1N1) viruses. Results Viral HA 1 and NA gene sequence analysis from the 4 patients revealed indistinguishable nucleotide sequences and phylogenetic clustering of H274Ymutated, oseltamivir-resistant influenza A(H1N1) virus, confirming nosocomial transmission. Influenza virus pneumonia (3 patients) and attributable mortality (2 patients) during active infection was observed in patients with lymphocytopenia at onset. Conclusion Seasonal oseltamivir-resistant influenza A(H1N1) viruses with NA gene H274Y mutation are transmitted and retain significant pathogenicity and lethality in high-risk patients.

Patient and family education in HSCT: improving awareness of respiratory virus infection and influenza vaccination. A descriptive study and brief intervention

“…Six patients developed pneumonia, and of these, 4 resulted in death from respiratory failure. [10][11][12] Preventing RV infection in HSCT recipients remains essential. The main preventive measures are influenza vaccination and avoiding contact with infected individuals.…”

Point-Counterpoint: Can Newly Developed, Rapid Immunochromatographic Antigen Detection Tests Be Reliably Used for the Laboratory Diagnosis of Influenza Virus Infections?

“…An outbreak in a hematologic/ oncologic unit resulted in 23/76 patients (32%) developing nosocomial influenza, three patients being identified with oseltamivir-resistant virus, and 3 patients expiring (27). An outbreak investigation in the Netherlands found nosocomial transmission of oseltamivir-resistant virus, leading to three cases of pneumonia and two mortalities (28).…”

Synthesis and Anti-influenza Activities of Novel Baicalein Analogs

“…6) Moreover, recent studies have indicated that pandemic H1N1 Tamiflu-resistant (H1N1 TR) viral isolates have been progressively rising, which may pose a risk for increasing fatality in human beings. 7,8) This means that development of new therapeutic agents are urgently needed and prompted us to synthesize some novel flavonoids and explore the possibility as potential anti-influenza agents.…”